Related Experiment Video
Updated: May 27, 2026
09:14
Surgical Approach to Full Soft Tissue Face Allograft Procurement for Vascularized Composite Allotransplantation
Published on: December 30, 2025
Progressive facial hemiatrophy - a case series.
Feroze Kaliyadan1, Kaberi Biswas, A D Dharmaratnam
1Department of Dermatology, Amrita Institute of Medical Sciences and Research Center, Kochi, India.
Indian Journal of Dermatology
|November 29, 2011
Summary
Progressive Facial Hemiatrophy (PFH) affects six female patients, detailing clinical and serological traits. Differentiating PFH from localized scleroderma is crucial due to limited medical management options.
Area of Science:
- Medical Science
- Dermatology
- Rare Diseases
Background:
- Progressive Facial Hemiatrophy (PFH) is a rare condition characterized by unilateral facial atrophy.
- Distinguishing PFH from other facial disfigurements, such as localized scleroderma, is clinically significant.
Purpose of the Study:
- To present a series of six female patients diagnosed with Progressive Facial Hemiatrophy.
- To highlight the clinical and serological features of PFH.
- To discuss current treatment strategies and emphasize diagnostic differentiation.
Main Methods:
- Case series presentation of six female patients.
- Review of clinical manifestations.
- Analysis of serological markers.
- Discussion of therapeutic interventions.
Main Results:
- Detailed description of the clinical presentation in six female patients with PFH.
- Identification of relevant serological findings.
- Evaluation of the efficacy and limitations of available treatments.
Conclusions:
- Progressive Facial Hemiatrophy requires careful differentiation from conditions like localized scleroderma.
- Current medical management options for PFH are limited.
- Further research into effective treatments for PFH is warranted.
